Lin, Tiffany, et al. “Tenapanor: A New Treatment Option for Hyperphosphatemia in End Stage Kidney Disease”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 25, Jan. 2022, pp. 77-83, doi:10.18433/jpps32284.